Evidence map›Paper›PMID 40236585›Full record

ReviewExploratory research in clinical and social pharmacy2025

Through the lens of rural patients and pharmacies: A content analysis of state level pharmacy benefit manager regulations and policies.

Tyler C Melton, MaryKathleen Ryan, Andrew M Stallings, Sang H Park, Cameron Lanier, Jordan Marie Ballou, Meagen Rosenthal

Abstract readReview
In one paragraph

Review in Exploratory research in clinical and social pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tyler C MeltonUniversity of Tennessee Health Science Center College of Pharmacy, Department of Clinical Pharmacy and Translational Science, United States of America.
MaryKathleen RyanUniversity of Tennessee Health Science Center College of Pharmacy, Department of Clinical Pharmacy and Translational Science, United States of America.
Andrew M StallingsUniversity of Tennessee Health Science Center College of Pharmacy, Department of Clinical Pharmacy and Translational Science, United States of America.
Sang H ParkUniversity of Tennessee Health Science Center College of Pharmacy, Department of Clinical Pharmacy and Translational Science, United States of America.
Cameron LanierBallad Health at Johnson City Medical Center, United States of America.
Jordan Marie BallouClinical Pharmacy and Outcomes Sciences, University of South Carolina College of Pharmacy, United States of America.
Meagen RosenthalSchool of Pharmacy at the University of Mississippi, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pharmacy Benefit Managers (PBMs) are responsible for establishing community pharmacy reimbursement practices and prices to varying degrees. Understanding PBMs' reimbursement practices is necessary for the continued viability of community pharmacies located in underserved and rural patient communities. Currently, there is a gap in literature exploring PBM reform and the impact this legislation has on rural pharmacy practice. Objectives: This content analysis reviews the legislation complied by the National Community Pharmacists Association (NCPA) and determines its benefits to pharmacies and patients in rural areas. Methods: The NCPA PBM Reform legislation document included bills from 48 states and the District of Columbia, that were introduced between November 30, 2018, through December 7, 2021. Bills were classified as enacted ( Results: Fifty-seven bills were included in the content analysis, where six categories were identified using thematic analysis and classified as: PBM Operations, Drug Pricing, Transparency, Reimbursements, Cost Sharing, and Prior Authorization. Only twenty-two bills were identified as potentially benefitting both rural pharmacies and rural patients through inclusion of legislation managing PBM practices involving patient steering, network adequacy, pricing transparency, reforming cost-sharing structures, and streamlining prior authorization processes. Conclusions: This study identifies multiple PBM legislation categories having the potential to impact rural pharmacy operations and patient outcomes. However, further research is needed to understand the specific financial and clinical impact of these PBM legislation categories on rural communities and rural pharmacy practice, as well as their alignment with enabling pharmacists to combat unique health disparities and challenges facing rural communities.

Indexed as

Pharmacy benefit managerRural healthRural pharmacy

Identifiers

PMID40236585
PMCPMC11999675

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.